Emerging Insights from Single-cell Analysis in Understanding T1d Autoimmunity
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas. Recent advances in single-cell…
Diabetic Lens
How Gene Therapy Is Being Used to Reprogram Immune Cells in T1d
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas. This leads to high blood sugar…
Novel Approaches to Reduce Autoimmune Memory Cells in T1d Patients
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks insulin-producing beta cells in the pancreas. A key challenge in managing…
The Use of Crispr-cas9 to Create Autoimmunity-resistant Beta Cells
Recent advances in genetic engineering have opened new possibilities for treating autoimmune diseases such as Type 1 diabetes. One promising approach involves…
Advances in Monitoring Autoimmune Activity to Enable Early Intervention in T1d
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas. Early detection of autoimmune…
The Role of Interleukin Blockade in Protecting Beta Cells from Autoimmune Damage
Autoimmune diseases such as Type 1 diabetes involve the immune system mistakenly attacking the body’s own cells. In this case, pancreatic beta cells, which…
Progress in Developing Tolerance-promoting Vaccines for T1d Prevention and Cure
Type 1 diabetes (T1D) is a chronic autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas. This condition often…
The Promise of Smart Drug Delivery Systems for Targeted Autoimmune Therapy
Autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and lupus, affect millions of people worldwide. These conditions occur when the body’s…
Innovative Approaches Using Synthetic Biology to Engineer Immune Cells for T1d
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system mistakenly attacks insulin-producing beta cells in the pancreas. Recent advances…
The Potential of Exosome-mediated Delivery of Autoimmune Modulators in T1d
Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks insulin-producing cells in the pancreas. Managing this condition remains…